HomeDocumentationLoginBook a demo
HomeLoginBook a demo

Theramex

Ownership
Private
Therapeutic Areas
Women's HealthEndocrinology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Pharmaceuticals for women’s health including hormonal therapies and other specialty medicines related to contraception, fertility, menopause, osteoporosis.

Theramex General Information

Theramex has established itself as a global leader in women’s health pharmaceuticals with commercial products addressing contraception, menopause, osteoporosis, fertility. The company has expanded its portfolio through acquisitions and new product launches. It focuses on patient-centric solutions supporting women at all life stages. Recent growth driven by operational transformation post-acquisition by private equity firms.

Contact Information

Website
https://www.theramex.com/
Primary Industry
Biotech
Corporate Office
HQ, London
United Kingdom

Drug Pipeline

ANNOVERA
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Theramex's pipeline data

Book a demo

Key Partnerships

Previously had commercialization partnership with Alvogen announced in June 2018.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Theramex Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Theramex's complete valuation and funding history, request access »

Theramex Financial Metrics

See full profile
Book a demo
OverviewDrug PipelineTechnologiesPartnershipsFundingCompetitorsAnalysisPatentsLicensing Deals